120 related articles for article (PubMed ID: 3471282)
1. Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid.
Okamoto S; Olson AC; Vogler WR; Winton EF
Blood; 1987 May; 69(5):1381-7. PubMed ID: 3471282
[TBL] [Abstract][Full Text] [Related]
2. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
3. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
Vogler WR; Somberg LB; Glasser L
Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
[TBL] [Abstract][Full Text] [Related]
4. Purging murine leukemic marrow with alkyl-lysophospholipids.
Glasser L; Somberg LB; Vogler WR
Blood; 1984 Dec; 64(6):1288-91. PubMed ID: 6388666
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
Verdonck LF; Heesbeen EC; van Heugten HG; Staal GE; Rijksen G
Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
[TBL] [Abstract][Full Text] [Related]
6. The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562.
Tidwell T; Guzman G; Vogler WR
Blood; 1981 Apr; 57(4):794-7. PubMed ID: 6937218
[TBL] [Abstract][Full Text] [Related]
7. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
Dulisch I; Neumann HA; Löhr GW; Andreesen R
Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
Vogler WR; Berdel WE; Olson AC; Winton EF; Heffner LT; Gordon DS
Blood; 1992 Sep; 80(6):1423-9. PubMed ID: 1520869
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
Vogler WR; Olson AC; Okamoto S; Somberg LB; Glasser L
Lipids; 1987 Nov; 22(11):919-24. PubMed ID: 3328027
[TBL] [Abstract][Full Text] [Related]
10. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
[TBL] [Abstract][Full Text] [Related]
11. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview.
Wötzel M; Brachwitz H; Langen P; Thierbach V
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880
[TBL] [Abstract][Full Text] [Related]
12. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
Hagenbeek A; Martens AC
Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel.
Duzkale H; Pagliaro LC; Rosenblum MG; Varan A; Liu B; Reuben J; Wierda WG; Korbling M; McMannis JD; Glassman AB; Scheinberg DA; Freireich EJ
Biol Blood Marrow Transplant; 2003 Jun; 9(6):364-72. PubMed ID: 12813444
[TBL] [Abstract][Full Text] [Related]
15. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
Allieri MA; Lopez M; Douáy L; Mary JY; NGuyen L; Gorin NC
Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
[TBL] [Abstract][Full Text] [Related]
16. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia.
Okamoto S; Olson AC; Berdel WE; Vogler WR
Blood; 1988 Nov; 72(5):1777-83. PubMed ID: 3052629
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
Rowley SD; Jones RJ; Piantadosi S; Braine HG; Colvin OM; Davis J; Saral R; Sharkis S; Wingard J; Yeager AM
Blood; 1989 Jul; 74(1):501-6. PubMed ID: 2665843
[TBL] [Abstract][Full Text] [Related]
18. Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.
Long RC; Small WC; Brynes RK; Tidwell T; Goldstein JH; Vogler WR
Cancer Res; 1983 Feb; 43(2):770-5. PubMed ID: 6571718
[TBL] [Abstract][Full Text] [Related]
19. Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. implications for bone marrow purging.
Lydaki E; Dimitriou H; Papazoglou T; Liu WQ; Kalmanti M
Leuk Res; 1997 Jul; 21(7):641-50. PubMed ID: 9301685
[TBL] [Abstract][Full Text] [Related]
20. Purging in autologous hematopoietic stem cell transplantation using adenosine triphosphate (ATP) and 4-hydroperoxycyclophosphamide (4-HC).
Hatta Y; Itoh T; Baba M; Miyajima T; Shimojima H; Sawada U; Horie T
Leuk Res; 2002 May; 26(5):477-82. PubMed ID: 11916522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
